Saliva Patterns After THC Capsules and Oromucosal Spray Did Not Support the Same Compliance Inference

Illustration of a printed chromatogram beside a sample vial and pen

Observed THC capsule dosing and THC/CBD mouth-spray dosing produced very different saliva patterns. A test used to monitor treatment must be matched to how the medicine enters the body.

Five conditions in fourteen people

Fourteen cannabis users completed randomized sessions with low- and higher-dose swallowed THC, low- and higher-dose THC/CBD spray, and placebo. Oral fluid was collected before dosing and for 10.5 hours afterward.

Capsules supplied 5 or 15 mg THC. Spray doses supplied 5.4 mg THC plus 5 mg CBD, or 16.2 mg THC plus 15 mg CBD. The experiment studied disposition, not an impairment diagnosis.

Local deposition changed the signal

After swallowed THC, parent THC generally declined from baseline and did not significantly differ from placebo after adjustment. Residual exposure before the session was important.

Spray administration substantially increased oral-fluid THC, CBD and CBN. The medicine directly contacted the mouth, creating a local cannabinoid source. This signal cannot be treated as though it came entirely from blood.

Adherence and additional smoking differ

The authors considered the high CBD-to-THC pattern potentially useful for documenting spray use. Absent parent THC did not reliably establish that a swallowed capsule had not been taken.

The spray’s own contamination complicated identifying additional smoked cannabis during treatment. A proposed ratio supporting recent exposure was not an exclusionary rule. One result cannot automatically establish adherence, detect every additional exposure and measure impairment.

Limits remain important

Baseline positivity, varied cannabis histories, a small sample and the 10.5-hour observation period constrain interpretation. Analyte-specific quantification limits also affected detection.

The paper contains an inconsistent final reference to the ratio characterizing spray use; its results and discussion identify CBD/THC as the relevant high ratio. Interpretation should follow those data rather than repeat isolated contradictory wording.

For the separate forensic question, see our discussion of cannabinoid concentrations and evidence of impairment.

Primary research

Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?. Drug and alcohol dependence (2012). DOI: 10.1016/j.drugalcdep.2012.10.011.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

What Did Mental Health Professionals Report After a Breathwork Workshop?

Ulrike Lueken and colleagues asked 48 mental health professionals to take part in a high-ventilation breathwork workshop and rate their experience. The participants reported altered states and also gave their judgments about possible therapeutic uses and risks. Those ratings describe the views of the workshop group. They do not measure…

Spread the love

Read Article: What Did Mental Health Professionals Report After a Breathwork Workshop?

What Changed on an Emotional Face Recognition Task After Psilocybin With Support?

In an open-label study, J. B. Stroud and colleagues found that people with treatment-resistant depression recognized facial emotions faster one month after receiving psilocybin with psychological support. Seventeen patients completed the task at baseline and follow-up. Sixteen untreated controls completed it on the same schedule. The researchers reported a group-by-time…

Spread the love

Read Article: What Changed on an Emotional Face Recognition Task After Psilocybin With Support?

What Did a Young-Adult CBD Survey Reveal About How Users Chose a Dose?

A survey of young adults asked how CBD users chose a dose. Their answers show why a product history needs more detail than a report of CBD use.

Spread the love

Read Article: What Did a Young-Adult CBD Survey Reveal About How Users Chose a Dose?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us